Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Account Payables (2016 - 2025)

Rockwell Medical's Change in Account Payables history spans 16 years, with the latest figure at $474000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 80.92% year-over-year to $474000.0; the TTM value through Dec 2025 reached -$870000.0, up 47.18%, while the annual FY2025 figure was -$870000.0, 47.18% up from the prior year.
  • Change in Account Payables reached $474000.0 in Q4 2025 per RMTI's latest filing, up from $23000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.6 million in Q2 2021 to a low of -$2.0 million in Q3 2023.
  • Average Change in Account Payables over 5 years is -$107800.0, with a median of $66000.0 recorded in 2022.
  • Peak YoY movement for Change in Account Payables: soared 755.26% in 2021, then crashed 1933.03% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at -$1.1 million in 2021, then skyrocketed by 191.51% to $1.0 million in 2022, then tumbled by 41.42% to $587000.0 in 2023, then plummeted by 55.37% to $262000.0 in 2024, then surged by 80.92% to $474000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Change in Account Payables are $474000.0 (Q4 2025), $23000.0 (Q3 2025), and -$423000.0 (Q2 2025).